ARCHIVES

FDA Committee Approves NDA for Mitxantrone

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational

October 10, 2014

Nominations Open for Bristol-Myers $25,000

September 29, 1978

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

ACS To Continue Supporting Both Treatment, Prevention Research, Leaders Say

May 1, 1987

NCCS Networker Volume 9 Issue 1, Spring 1995

April 13, 1995

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006